An economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol

被引：0
|
作者：
Russell, JM [1 ]
Mackell, JA [1 ]
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80345-6
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [21] Subjective tolerability with ziprasidone vs haloperidol in acute schizophrenia
    Awad, AG
    Voruganti, LN
    Mackell, JA
    Siu, CO
    VALUE IN HEALTH, 2003, 6 (03) : 360 - 360
  • [22] Intramuscular Midazolam, Olanzapine, Ziprasidone, or Haloperidol for Treating Acute Agitation
    Zeller, Scott
    Wilson, Michael
    Nordstrom, Kimberly
    ANNALS OF EMERGENCY MEDICINE, 2019, 73 (04) : 422 - 423
  • [23] Economic evaluations of olanzapine and risperidone
    Shaw, JW
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (14) : 1366 - 1375
  • [24] Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis
    Moteshafi, Hoda
    Stip, Emmanuel
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) : 713 - 732
  • [25] Ethnicity and schizophrenia medication choice: Haloperidol, risperidone, or olanzapine
    Opolka, JL
    Rascati, KL
    Brown, CM
    Gibson, PJ
    VALUE IN HEALTH, 2003, 6 (03) : 345 - 345
  • [26] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    D. Gothelf
    A. Apter
    J. Reidman
    A. Brand-Gothelf
    Y. Bloch
    G. Gal
    L. Kikinzon
    S. Tyano
    R. Weizman
    G. Ratzoni
    Journal of Neural Transmission, 2003, 110 : 545 - 560
  • [27] Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium
    Grover, Sandeep
    Kumar, Vineet
    Chakrabarti, Subho
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2011, 71 (04) : 277 - 281
  • [28] Social cognition and neurocognition: Effects of risperidone, olanzapine, and haloperidol
    Sergi, M. J.
    Green, M. F.
    Widmark, C.
    Reist, C.
    Erhart, S.
    Braff, D. L.
    Kee, K. S.
    Mintz, J.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 478 - 478
  • [29] Comment: risk or extrapyramidal syndromes with haloperidol, risperidone, or olanzapine
    Lu, ML
    Shen, WW
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (7-8) : 1292 - 1292
  • [30] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    Gothelf, D
    Apter, A
    Reidman, J
    Brand-Gothelf, A
    Bloch, Y
    Gal, G
    Kikinzon, L
    Tyano, S
    Weizman, R
    Ratzoni, G
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (05) : 545 - 560
12345